Oxford Asset Management’s CareDx CDNA Stock Holding History

Oxford Asset Management’s Portfolio CDNA Stock Details CDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-8,103	Closed	-$233K	–	1808
2018 Q3	$233K	Buy	+8,103	New	+$152K	﹤0.01%	1561
2018 Q2	–	Sell	-45,233	Closed	-$361K	–	1716
2018 Q1	$361K	Buy	+45,233	New	+$279K	0.01%	1350

Other funds holding CDNA

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

ICM

ISZO Capital Management New York $2M AUM 35.61% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

NCGI

Next Century Growth Investors Plymouth, Minnesota $1.38B AUM 102.34% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Oxford Asset Management's CDNA Position: Q4 2018 in Review

Oxford Asset Management sold out of CareDx (CDNA) in Q4 2018, closing a stake of 8,103 shares — an estimated $233K sold.

Oxford Asset Management first reported a position in CDNA in Q1 2018 and held it in 2 quarters. The position peaked at $361K in Q1 2018. 148 funds tracked by Wall St. Rank hold CDNA as of Q4 2018.

Oxford Asset Management reported no remaining CareDx position as of Q4 2018 after selling out during the quarter.
Oxford Asset Management sold 8,103 CareDx shares in Q4 2018, an estimated $233K.
Oxford Asset Management first reported a position in CareDx in Q1 2018 and held it in 2 quarters.
Oxford Asset Management's CareDx position peaked at $361K in Q1 2018.
148 funds tracked by Wall St. Rank held CareDx as of Q4 2018.

Based on Oxford Asset Management's 13F filing for Q4 2018, filed 14 Feb 2019.